Brief: F D C Ltd Gets ANDA Approval For Ofloxacin Otic Solution, 0.3% From U.S. FDA
21/01/2022 13:54
Jan 21 (Reuters) - F D C Ltd FDC.NS :
* F D C LTD - RECEIVED ANDA APPROVAL FOR OFLOXACIN OTIC
SOLUTION,
0.3% FROM U.S. FDA
Source text for Eikon: ID:nBSEn84m4
Further company coverage: FDC.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on FDC
See all newsBrief: FDC To Consider Proposal For Buyback Of Equity Shares Via Tender Offer
Brief: F D C Says High Court Granted Interim Stay To Impugned Notice Of FSSAI
Brief: F D C June-Quarter Consol Profit 1.32 Billion Rupees
India's FDC drops after Maharashtra FDA seizes certain 'Enerzal' stock
Brief: F D C Says Food Safety Officials Visited Company's Warehouse At Chhatrapati Sambhaji Nagar And Nagpur